Biopharmaceutical company Hansa Medical AB, has acquired Immago Biosystems Ltd, a therapeutic antibodies developer in glycobiology.
Hansa Medical AB expects that the transaction will provide it with rights to cancer immunotherapy using antibody-modulating enzymes.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Qingdao Gon Technology has announced its plans to acquire an undisclosed pharmaceutical company.
The company expects the acquisition to cost them up to $26.59m.
